KRANEMAR
ActiveSummary
KRANEMAR has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €235,796 and a net result of €48,874. Equity is growing by ~7.8% per year across the filed fiscal years. Its solvency ranks better than 92% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability94▲+13
Solvency100=
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €22,000 at 30 days acceptable
Liquidity ample (current ratio 16.63 against 70.89 in 2024; short-term debt: 4.4% and cash: 23.3% of total assets), and 4.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
95.6%
Return on assets
19.8%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
27 d late
2024
30 d late
2023
27 d late
2022
30 d late
2021
21 d late
2020
16 d late
2019
69 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 31 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 28 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€235,796▲ 26.1%
2024 · €186,921
Total assets
€246,520▲ 30.5%
2024 · €188,959
Net result
€48,874▲ 155%
2024 · €19,176
Working capital
€167,594▲ 17.7%
2024 · €142,424
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€39,439▲ 12.4%€49,845▲ 26.4%€25,415▼ 49.0%€28,117▲ 10.6%€68,601▲ 144%
Net result€26,109within the sector's middle half▲ 26.1%€32,476within the sector's middle half▲ 24.4%€17,339below the sector's middle half▼ 46.6%€19,176below the sector's middle half▲ 10.6%€48,874within the sector's middle half▲ 155%
Equity€156,621within the sector's middle half▼ 4.3%€189,097within the sector's middle half▲ 20.7%€167,745within the sector's middle half▼ 11.3%€186,921within the sector's middle half▲ 11.4%€235,796within the sector's middle half▲ 26.1%
Total assets€190,284within the sector's middle half▼ 10.3%€211,095within the sector's middle half▲ 10.9%€183,917within the sector's middle half▼ 12.9%€188,959within the sector's middle half▲ 2.7%€246,520within the sector's middle half▲ 30.5%
Debt€33,662▼ 30.7%€21,998▼ 34.6%€16,172▼ 26.5%€2,038▼ 87.4%€10,725▲ 426%
Working capital€101,188within the sector's middle half▼ 5.6%€143,209within the sector's middle half▲ 41.5%€120,945within the sector's middle half▼ 15.5%€142,424within the sector's middle half▲ 17.8%€167,594within the sector's middle half▲ 17.7%
Solvency82.3%within the sector's middle half▲ 5.2pp89.6%above the sector's middle half▲ 7.3pp91.2%above the sector's middle half▲ 1.6pp98.9%above the sector's middle half▲ 7.7pp95.6%above the sector's middle half▼ 3.3pp
Current ratio5.17within the sector's middle half▲ 1.129.63above the sector's middle half▲ 4.459.16above the sector's middle half▼ 0.4770.89above the sector's middle half▲ 61.7316.63above the sector's middle half▼ 54.27
Return on assets (ROA)13.7%within the sector's middle half▲ 4.0pp15.4%within the sector's middle half▲ 1.7pp9.4%within the sector's middle half▼ 6.0pp10.1%within the sector's middle half▲ 0.7pp19.8%within the sector's middle half▲ 9.7pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 144% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €246,520
Fixed assets
€68,202 ▲ 53.3%
Current assets
€178,319 ▲ 23.4%
Equity and liabilities €246,520
Equity
€235,796 ▲ 26.1%
Debt
€10,725 ▲ 426%
Debt's share of the balance-sheet total rises from 1.1% to 4.4%. Equity and debt are higher.
Key figures and ratios
EBITDA
€85,997▲
2024 · €45,965
Cash flow
€66,270▲
2024 · €37,024
Debt to equity
0.05▲
2024 · 0.01
ROE
20.7%▲
2024 · 10.3%
Interest coverage
390.58▲
2024 · 125.50
Debt ≤ 1 year
€10,725▲
2024 · €2,038
Income taxes
€22,791▲
2024 · €10,690
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 34,679 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.6%
went bankrupt
3.8%
stopped otherwise
95%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 34,679 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €18,642 | €17,598 | €19,027 | €17,848 | €17,396 | ▼ 2.5% |
| Other operating charges640/8 | €552 | €461 | €422 | €520 | €264 | ▼ 49.3% |
| Gross operating margin9900 | €58,632 | €67,903 | €44,865 | €46,485 | €86,261 | ▲ 85.6% |
| Operating profit (loss)9901 | €39,439 | €49,845 | €25,415 | €28,117 | €68,601 | ▲ 144% |
| Financial income75/76B | €1,180 | €1,660 | €1,812 | €2,116 | €3,285 | ▲ 55.3% |
| Recurring financial income75 | €1,180 | €1,660 | €1,812 | €2,116 | €3,285 | ▲ 55.3% |
| Financial charges65/66B | €277 | €264 | €237 | €366 | €220 | ▼ 39.9% |
| Recurring financial charges65 | €277 | €264 | €237 | €366 | €220 | ▼ 39.9% |
| Profit (loss) for the period before taxes9903 | €40,342 | €51,241 | €26,990 | €29,866 | €71,665 | ▲ 140% |
| Income taxes67/77 | €14,233 | €18,765 | €9,651 | €10,690 | €22,791 | ▲ 113% |
| Profit (loss) for the period9904 | €26,109 | €32,476 | €17,339 | €19,176 | €48,874 | ▲ 155% |
| Profit (loss) for the period to be appropriated9905 | €26,109 | €32,476 | €17,339 | €19,176 | €48,874 | ▲ 155% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €190,284 | €211,095 | €183,917 | €188,959 | €246,520 | ▲ 30.5% |
| Fixed assets21/28 | €64,850 | €51,287 | €48,154 | €44,497 | €68,202 | ▲ 53.3% |
| Tangible fixed assets22/27 | €64,318 | €50,755 | €47,622 | €43,965 | €67,669 | ▲ 53.9% |
| Land and buildings22 | - | - | - | €9,038 | €8,114 | ▼ 10.2% |
| Plant, machinery and equipment23 | €17,067 | €12,030 | €9,408 | €7,975 | €4,269 | ▼ 46.5% |
| Furniture and vehicles24 | €22,191 | €15,372 | €8,552 | €3,100 | €37,245 | ▲ 1,101% |
| Other tangible fixed assets26 | €25,060 | €23,353 | €29,662 | €23,851 | €18,041 | ▼ 24.4% |
| Financial fixed assets28 | €533 | €533 | €533 | €533 | €533 | = |
| Current assets29/58 | €125,433 | €159,808 | €135,763 | €144,462 | €178,319 | ▲ 23.4% |
| Amounts receivable within one year40/41 | €18,174 | €29,974 | €6,253 | €13,116 | €17,204 | ▲ 31.2% |
| Other amounts receivable41 | €18,174 | €29,974 | €6,253 | €13,116 | €17,204 | ▲ 31.2% |
| Current investments50/53 | - | - | €75,000 | €75,000 | €100,000 | ▲ 33.3% |
| Cash at bank and in hand54/58 | €107,259 | €129,835 | €52,017 | €53,720 | €57,417 | ▲ 6.9% |
| Deferred charges and accrued income490/1 | - | - | €2,493 | €2,626 | €3,698 | ▲ 40.8% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €190,284 | €211,095 | €183,917 | €188,959 | €246,520 | ▲ 30.5% |
| Equity10/15 | €156,621 | €189,097 | €167,745 | €186,921 | €235,796 | ▲ 26.1% |
| Contributions10/11 | €6,200 | €6,200 | €6,200 | €6,200 | €6,200 | = |
| Reserves13 | €150,421 | €182,897 | €161,545 | €180,721 | €229,596 | ▲ 27.0% |
| Non-distributable reserves130/1 | €1,860 | €1,860 | €1,860 | €1,860 | - | - |
| Reserves not available under the articles1311 | €1,860 | €1,860 | €1,860 | €1,860 | - | - |
| Distributable reserves133 | €148,561 | €181,037 | €159,685 | €178,861 | €229,596 | ▲ 28.4% |
| Amounts payable17/49 | €33,662 | €21,998 | €16,172 | €2,038 | €10,725 | ▲ 426% |
| Amounts payable after more than one year17 | €9,417 | €5,399 | €1,354 | - | - | - |
| Financial debts170/4 | €9,417 | €5,399 | €1,354 | - | - | - |
| Amounts payable within one year42/48 | €24,245 | €16,599 | €14,818 | €2,038 | €10,725 | ▲ 426% |
| Current portion of amounts payable after more than one year42 | €3,991 | €4,018 | €4,045 | €1,354 | - | - |
| Trade debts44 | €918 | €1,853 | €3,596 | €683 | €3,530 | ▲ 417% |
| Suppliers440/4 | €918 | €1,853 | €3,596 | €683 | €3,530 | ▲ 417% |
| Taxes, remuneration and social security45 | €19,336 | €10,728 | €7,178 | - | €7,195 | - |
| Taxes450/3 | €19,336 | €10,728 | €7,178 | - | €7,195 | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €26,109 | €32,476 | €17,339 | €19,176 | €48,874 | ▲ 155% |
| + Depreciation and write-downs630 | €18,642 | €17,598 | €19,027 | €17,848 | €17,396 | ▼ 2.5% |
| Operating cash flow (approximation) | €44,750 | €50,073 | €36,366 | €37,024 | €66,270 | ▲ 79.0% |
| Investment in fixed assets (approximation) | - | -€4,034 | -€15,894 | -€14,191 | -€41,101 | ▼ 190% |
| Change in cash | - | €22,576 | -€77,818 | €1,702 | €3,698 | ▲ 117% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
31-12
Financial
Highest result since 2018net €48,874 ▲155%
Operating result €68,601, net result €48,874, both a record.
31-12
Financial
Equity above €200,000Eq €235,796 ▲26.1%
8 profitable years in a row build equity to €235,796.
30-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 30 days late
2024
31-12
Financial
Liquidity times 8current ratio 70.89
Current ratio from 9.16 to 70.89; short-term debt falls from €14,818 to €2,038.
27-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 27 days late
2023
31-12
Financial
Weakest financial yearnet €17,339 ▼46.6%
Net result drops to €17,339, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
2022
21-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 21 days late
2021
16-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 16 days late
2020
31-12
Financial
Equity above €150,000Eq €163,681 ▲9.3%
3 profitable years in a row build equity to €163,681.
08-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 69 days late
Show earlier events
2019
06-09
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 37 days late
2018
28-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 28 days late
2017
25-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beernem · 1 establishment unit since 2010
Ground area
652 m²
Building footprint
218 m²
Volume, LiDAR
1,210 m³
Parcel 31003D0031/00B003, Flanders · tallest building 12.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Kranemar
since 20102.185.626.269
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31003D0031/00B003 | Flanders | 652 m² | 1 · 218 m² | 12.3 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2024 to 2025 · 2 entries · 417 EUR awarded · 417 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 315 EUR | 315 EUR |
| 2024 | 1 | 102 EUR | 102 EUR |
Similar companies · same sector, comparable size
Kine Don Bosco
BE 0839.851.536
Torhout · Eq €236,578
Centrum voor Motorische Revalidatie en Kinesitherapie
BE 0437.968.163
Hemiksem · Eq €234,586
Sport Medisch Centrum Sente
BE 0774.640.713
Sint-Laureins · Eq €237,347
KINE OLINE
BE 0735.745.295
Charleroi · Eq €237,795
PODKIN
BE 0876.548.814
Aalst · Eq €237,908
Of 12,699 companies in sector 86951 we hold annual accounts for 2,146. 1,531 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded11-02-2010
Fiscal year end31-12
Activities, NACEBEL 2025
86951Physiotherapy
E-invoicing
Reachable via Peppol
Peppol ID
0208:0823311848
Also
9925:BE0823311848
Registered
25-11-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.